Table 3.
EQD2 dose received by 2 cc OARs
| Organs at risk | Group | N | Mean | Std. deviation | Min | Max | p value | 95% CI of the difference | |
|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||||
| Sigmoid Colon | GA | 16 | 62.2031 | 8.33009 | 49.68 | 77.05 | .789 | − 6.04624 | 4.62828 |
| PS | 19 | 62.9121 | 7.19461 | 50.99 | 79.74 | ||||
| Bladder | GA | 16 | 79.5156 | 10.70180 | 51.18 | 95.62 | .677 | − 5.94628 | 9.03964 |
| PS | 19 | 77.9689 | 10.97947 | 56.64 | 96.24 | ||||
| Rectum | GA | 16 | 63.4744 | 5.78111 | 54.86 | 77.48 | .024* | − 11.27340 | − .86417 |
| PS | 19 | 69.5432 | 8.73826 | 54.21 | 90.95 | ||||
* p-values are significant at 5% level of significance